Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
571
NCT00538434
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
Phase: Phase 2/3
Role: Lead Sponsor
Start: Mar 31, 2008
Completion: Oct 31, 2009
NCT00587288
Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma
Phase: Phase 2
Start: Apr 30, 2008
Completion: Mar 31, 2010
NCT00635089
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis
Phase: Phase 3
Start: Jul 31, 2008
Completion: Jan 31, 2012
NCT03642964
A Study in Patients With Major Depressive Disorder
Start: Sep 10, 2018
Completion: Dec 30, 2025
NCT03683225
A Study to Evaluate in Patients With Parkinsonian Type Disorders
Start: Apr 1, 2019